Severe ulcerative gastrointestinal toxicity following ibrutinib therapy: two case studies
Leuk Lymphoma
.
2021 Apr;62(4):984-987.
doi: 10.1080/10428194.2020.1845333.
Epub 2020 Nov 12.
Authors
Lucas Pacoureau
1
,
Mathilde De Menthon
1
,
Isabelle Boytchev
2
,
Thierry Lazure
3
,
Laurence Rocher
4
5
,
Olivier Lambotte
1
5
6
7
,
Nicolas Noël
1
5
6
7
Affiliations
1
Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine and Clinical Immunology, Bicetre Hospital, Le Kremlin Bicêtre, France.
2
Assistance Publique - Hôpitaux de Paris, Department of Gastroenterology, Bicetre Hospital, Le Kremlin BIcêtre, France.
3
Assistance Publique - Hôpitaux de Paris, Department of Pathology, Bicetre Hospital, Le Kremlin BIcêtre, France.
4
Assistance Publique - Hôpitaux de Paris, Department of Radiology, Antoine Beclere Hospital, Clamart, France.
5
Paris Saclay University, Le Kremlin Bicêtre, France.
6
INSERM UMR 1184 Unit, Center for Immunology of Viral and Autoimmune Diseases, Paris Saclay University, Le Kremlin-Bicêtre, France.
7
Commissariat à l'Energie Atomique (CEA), Division of Immuno-Virology, IDMIT, Fontenay-aux-Roses, France.
PMID:
33179997
DOI:
10.1080/10428194.2020.1845333
No abstract available
Publication types
Letter
MeSH terms
Adenine / analogs & derivatives
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Piperidines
Pyrazoles / adverse effects
Pyrimidines* / adverse effects
Substances
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine